( R R 9 .3 - & -4 R i i & - \ & C Ce: S.

Katherine E.

_ iO 2 3M Company EPI-0013 Page 1 of 36 FINAL REPORT Epidemiology Medical Department 3M Company St.

Ad<3.>-- noi TOXIKON FINAL REPORT: 01-7019-G1 CHO/HGPRT FORWARD MUTATION ASSAY - ISO (T-6889.7) Author Devaki Sadhu, Ph.D.

SRPTT-7.f -A a a s - 1*200 MIN 314/022208 n u Anilin* 0a 0 ^ 0 Z -O m ro ro -~c?

DRAFT m S .M - I& 7 Y Telomer Research Program 2003APR 2 ^ PM 2 : 0 7 LC/MS/MS Analysis of Articles and Products: Samples and Suggested Sampling Procedures Marilyn A.

03/13/2003 10:06 LJU DEP LEGAL SERVICES * 915133810205 3 3 /1 2 /2 0 0 3 1 5 :4 0 GOVERNOR'S PRESS OFFICE * 9 5 5 0 6 5 7 6 $3/12/03 WED 10:20 F41 20*8*22862 EWC NO.129 505 NO. 372 C?

AR226-1741 Toxicological Summary PFOS Dietary Chronic Definitive Reproductive Study: Mallard Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro, potassium salt.

3CMmrMpwtdsftceaTl oDkcoploargtyveat 3SMt.

3M Specialty Materials March 13, 2002 3M Center St.

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE February 2005 Click on Study Title to View Report February 10, 2005 Geary Olsen and Larry Zobel (3M), Comments of the 3M Company to the EPA Sci ence Advisory Board PFOA Review Panel, February 10, 2005 February 10, 2005 John A.

AR226-2359 J DRAFT PHASE II QUALITY ASSURANCE PROJECT PLAN DUPONT WASHINGTON WORKS SITE WASHINGTON, WEST VIRGINIA ) Date: March 2004 Project No.: 507532 18983990.04006 ||S |) 'i l i r CORPORATE REMEDIATION GROUP An Alliance between DuPont and URS Diamond Barley Mill Plaza, Building 27 Wilmington, Delaware 19805 EXP000431 Draft Document Do Not Gite or Quote, March 30, 2004 Draft Phase II Quality Assurance Project Plan Table of Contents TABLE OF CONTENTS 1.0 Project Management........................................................... ........................................ 1 1.1 Project Background...............................................................................................1 1.2 Project Description..............................................................................................2 1.3 Project Organization............................................................................................. 3 1.3.1 Project Director..................................................................................... 3 1.3.2 Project Manager.............................................................. 4 1.3.3 Health and Safety Officer........................................ 4 1.3.4 Project Geologist..................................................... 4 1.3.5 Technical Consultants............................................................................ 4 1.3.6 Technical and Support Staff.................................................................. 4 1.3.7 Quality Assurance Officer.................................................. 5 1.3.8 Project Chemist................... !.........................................................

AR226-2500 Septem ber 17,2001 CONFIDENTIAL CERTIFIED M AIL RETURN RECEIPT REQUESTED M s.

P-1 Sanitized Version for the AR-226 Public Printed Copy File fCBI removed: copy restricted materials included as read only) Index DOCUMENT DESCRIPTION NO.

Commercial-in-Confidence Chemex reference: ENV8010/020737 P-1 Sa* , * 9 0 The growth inhibition of the marine alga Skeletonema costatum by CJ Report for Notox B.V Report issued by: Chemex Environmental International Limited Unit J Broad Lane Industrial Estate Cottenham Cambridge CB24 8SW England April 2007 Sponsor: Notox B.V Hambakenwetering 7 P.O.